The protective effects of CAT on lipid clearance and lipo-apoptosis were eliminated by co-treatment with CQ, which indirectly revealed the significance of CAT-induced autophagy in mitigating the development of NAFLD [102]. Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.